Capital Anesthesia Partners’ Clinical Research Division is dedicated to improving outcomes in anesthesia and gastroenterology while reducing procedural risk in the outpatient endoscopy setting. To date, we have completed nine research studies and published select findings that directly inform and enhance clinical practice.
Most anesthesia practices limit quality initiatives to internal reviews. Our approach goes further. We bring together every member of the care team to drive meaningful improvement.
Our research and quality programs include:
This collaborative model ensures that challenges are identified early, addressed comprehensively, and resolved efficiently—resulting in greater consistency, safety, and control across the anesthesia program.
Our studies are designed with one goal: to improve patient care and operational performance in real-world settings. We focus not only on anesthesia-related variables, but also on factors that matter to proceduralists and facility partners.
Key areas of focus include:
Our findings have led to meaningful changes in clinical protocols—both within our own practice and across partner facilities nationwide.
We welcome the opportunity to share more about our research initiatives and how they can support your facility’s clinical and operational goals. Contact us to learn more.
For the second time, Capital Anesthesia Partners was selected to present clinical research at the American College of Gastroenterology’s annual conference in Phoenix—highlighting our continued commitment to advancing outpatient care through evidence-based innovation.
Our poster was led by Chief Medical Officer Dr. Steven Saltzman, in collaboration with Dr. Aamir Ali and Dr. Dominique Howard of Capital Digestive Care, along with Justin Kweit, BSc. Together, the team examined how to safely reduce intravenous (IV) fluid use during gastrointestinal procedures.
This study was initiated in response to the national saline shortage following Hurricane Helene in September 2024. Faced with limited supply, our ambulatory surgery centers implemented a more targeted IV fluid protocol—creating an opportunity to evaluate its safety and effectiveness at scale.
Over a five-month study period:
These findings demonstrate that a more conservative, data-driven approach to IV fluid management can maintain patient safety while improving resource utilization. The results are already helping to inform clinical protocols across our partner facilities.
Capital Anesthesia Partners remains committed to leading research that enhances patient outcomes, supports our clinical partners, and strengthens the delivery of outpatient care.
Capital Anesthesia Partners was selected to present clinical research at the American College of Gastroenterology’s annual conference in San Antonio, further demonstrating our commitment to advancing patient safety in the outpatient setting.
The study was led by Chief Medical Officer Dr. Steven Saltzman, in collaboration with Dr. Aamir Ali and Dr. Michael Weinstein (now retired) of Capital Digestive Care. Together, the team investigated factors contributing to increased respiratory risk during certain endoscopic procedures.
Our research identified meaningful risk differentials associated with procedural positioning and case type:
These findings have helped inform procedural planning and anesthesia protocols across our practice and partner facilities. By identifying and mitigating risk factors in real time, we continue to enhance patient safety and support better outcomes in outpatient endoscopy.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.